These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22640434)

  • 1. New horizons in treating disorders of hyperpigmentation in skin of color.
    Konda S; Geria AN; Halder RM
    Semin Cutan Med Surg; 2012 Jun; 31(2):133-9. PubMed ID: 22640434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperpigmentation: old problem, new therapies.
    Que SK; Bergstrom KG
    J Drugs Dermatol; 2009 Sep; 8(9):879-82. PubMed ID: 19746682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of hyperpigmentation in darker racial ethnic groups.
    Grimes PE
    Semin Cutan Med Surg; 2009 Jun; 28(2):77-85. PubMed ID: 19608057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined therapy using Q-switched ruby laser and bleaching treatment with tretinoin and hydroquinone for periorbital skin hyperpigmentation in Asians.
    Momosawa A; Kurita M; Ozaki M; Miyamoto S; Kobayashi Y; Ban I; Harii K
    Plast Reconstr Surg; 2008 Jan; 121(1):282-288. PubMed ID: 18176232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disorders of hyperpigmentation. Part II. Review of management and treatment options for hyperpigmentation.
    Ko D; Wang RF; Ozog D; Lim HW; Mohammad TF
    J Am Acad Dermatol; 2023 Feb; 88(2):291-320. PubMed ID: 35158001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postinflammatory hyperpigmentation in patients with skin of color.
    Shokeen D
    Cutis; 2016 Jan; 97(1):E9-E11. PubMed ID: 26919365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined therapy using Q-switched ruby laser and bleaching treatment with tretinoin and hydroquinone for acquired dermal melanocytosis.
    Momosawa A; Yoshimura K; Uchida G; Sato K; Aiba E; Matsumoto D; Yamaoka H; Mihara S; Tsukamoto K; Harii K; Aoyama T; Iga T
    Dermatol Surg; 2003 Oct; 29(10):1001-7. PubMed ID: 12974695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal treatments for hyperpigmentation.
    Ke MS; Soriano T; Lask GP
    J Cosmet Laser Ther; 2006 Apr; 8(1):7-13. PubMed ID: 16581679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postinflammatory hyperpigmentation: etiologic and therapeutic considerations.
    Callender VD; St Surin-Lord S; Davis EC; Maclin M
    Am J Clin Dermatol; 2011 Apr; 12(2):87-99. PubMed ID: 21348540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical treatments for melasma and postinflammatory hyperpigmentation.
    Lynde CB; Kraft JN; Lynde CW
    Skin Therapy Lett; 2006 Nov; 11(9):1-6. PubMed ID: 17075653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postinflammatory hyperpigmentation: A comprehensive overview: Treatment options and prevention.
    Chaowattanapanit S; Silpa-Archa N; Kohli I; Lim HW; Hamzavi I
    J Am Acad Dermatol; 2017 Oct; 77(4):607-621. PubMed ID: 28917452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New and experimental treatments of cloasma and other hypermelanoses.
    Picardo M; Carrera M
    Dermatol Clin; 2007 Jul; 25(3):353-62, ix. PubMed ID: 17662901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperpigmentation: an overview of the common afflictions.
    Cayce KA; McMichael AJ; Feldman SR
    Dermatol Nurs; 2004 Oct; 16(5):401-6, 413-6; quiz 417. PubMed ID: 15624705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A therapeutic strategy based on histological assessment of hyperpigmented skin lesions in Asians.
    Kurita M; Kato H; Yoshimura K
    J Plast Reconstr Aesthet Surg; 2009 Jul; 62(7):955-63. PubMed ID: 18456589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of localised hyperpigmentation in black skin].
    Sulimovic L
    Ann Dermatol Venereol; 2006 Nov; 133(11):940-4. PubMed ID: 17127845
    [No Abstract]   [Full Text] [Related]  

  • 16. Acne in patients with skin of color: practical management.
    Yin NC; McMichael AJ
    Am J Clin Dermatol; 2014 Feb; 15(1):7-16. PubMed ID: 24190453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the Safety and Efficacy of a Topical Formulation Containing Epidermal Growth Factor, Tranexamic Acid, Vitamin C, Arbutin, Niacinamide and Other Ingredients as Hydroquinone 4% Alternatives to Improve Hyperpigmentation: A Prospective, Randomized, Controlled Split Face Study.
    Kalasho BD; Minokadeh A; Zhang-Nunes S; Zoumalan RA; Shemirani NL; Waldman AR; Pletzer V; Zoumalan CI
    J Cosmet Sci; 2020; 71(5):263-290. PubMed ID: 33022197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of post-inflammatory hyperpigmentation in skin of color: A short review.
    Anvery N; Christensen RE; Dirr MA
    J Cosmet Dermatol; 2022 May; 21(5):1837-1840. PubMed ID: 35289059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pretreatment on the incidence of hyperpigmentation following cutaneous CO2 laser resurfacing.
    West TB; Alster TS
    Dermatol Surg; 1999 Jan; 25(1):15-7. PubMed ID: 9935086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin lightening preparations and the hydroquinone controversy.
    Draelos ZD
    Dermatol Ther; 2007; 20(5):308-13. PubMed ID: 18045355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.